Biopact CT
Biopact CT is currently oversold!
Join the wait list:
The company may continue to accept investments on a select basis. If you would like to apply to invest and be added to the waitlist, please fill out the following form:
Oops! You need to be logged in to use this form.
Biopact CT
Patented technology that makes fighting disease simpler, faster, and cheaper.
Offering Type: Regulation CF
Price per share: $1.55
Valuation: $30 million